|1.||Srikumaran, Subramaniam: 8 articles (11/2014 - 10/2007)|
|2.||Kachlany, Scott C: 7 articles (11/2015 - 09/2008)|
|3.||Johansson, A: 7 articles (04/2011 - 10/2002)|
|4.||Claesson, R: 5 articles (01/2011 - 10/2002)|
|5.||Johansson, Anders: 4 articles (01/2015 - 06/2005)|
|6.||Nagaraja, T G: 4 articles (02/2008 - 09/2001)|
|7.||Maheswaran, Samuel K: 4 articles (10/2007 - 12/2002)|
|8.||Hänström, L: 4 articles (01/2005 - 10/2002)|
|9.||Kalfas, S: 4 articles (01/2005 - 10/2002)|
|10.||Belinka, Benjamin A: 3 articles (06/2015 - 10/2011)|
|1.||Enzootic Bovine Leukosis (Bovine Leukosis)
11/01/1990 - "All of the deletions eliminated the lytic activity of the leukotoxin towards the bovine lymphoma cell line, BL-3. "
02/12/1999 - "These studies were designed to test if leukotoxin causes release of the cytoskeletal protein, actin, from bovine leukemia cells and if purified actin-influenced bacterial growth or leukotoxin production. "
08/01/1995 - "haemolytica, but not from the mutant, contained the 102-kDa leukotoxin protein and lysed bovine lymphoma cells and sheep erythrocytes. "
02/01/1989 - "Leukotoxin activity from culture supernatants of Pasteurella haemolytica serotype 1 in logarithmic growth phase caused rapid (less than 5 min) release of intracellular K+, uptake of extracellular Ca2+, and swelling of cultured bovine lymphoma cells (BL3 cells). "
02/01/1989 - "Effects of Pasteurella haemolytica leukotoxin on cultured bovine lymphoma cells."
|2.||Uterine Diseases (Endometrial Disease)
01/01/2014 - "In this study we evaluate the efficacy of five vaccine formulations containing different combinations of proteins (FimH; leukotoxin, LKT; and pyolysin, PLO) and/or inactivated whole cells (Escherichia coli, Fusobacterium necrophorum, and Trueperella pyogenes) in preventing postpartum uterine diseases. "
04/01/1996 - "Culture supernatant was more protective than whole-cell culture or semipurified leukotoxin against experimentally induced hepatic abscesses. "
02/01/1994 - "necrophorum leukotoxin is highly antigenic and that anti-leukotoxin antibody titer is related to the severity of hepatic abscesses."
02/01/1994 - "Serum neutralizing antibodies against Fusobacterium necrophorum leukotoxin in cattle with experimentally induced or naturally developed hepatic abscesses."
04/01/1996 - "To determine the efficacy of leukotoxin-based Fusobacterium necrophorum vaccines and dietary tylosin in providing protection against experimentally induced hepatic abscesses in steers. "
02/01/1994 - "The relationship between serum-neutralizing antibody against Fusobacterium necrophorum leukotoxin and hepatic abscesses was investigated in cattle fed diets supplemented with or without tylosin. "
|4.||Psoriasis (Pustulosis Palmaris et Plantaris)
02/01/1991 - "This study was designed to investigate whether or not leukotoxin participates in lung injury in ARDS and coagulation abnormality which is often associated with ARDS. "
12/01/2002 - "Accumulating scientific evidence implicates leukotoxin as the primary factor contributing to clinical presentation and lung injury associated with this disease. "
09/01/1995 - "To investigate how mitochondrial function was affected in leukotoxin (Lx)-,9,10-epoxy-12-octadecenoate-induced lung injury, lung mitochondria were extracted from isolated perfused rat lung with or without Lx-induced edematous injury. "
02/01/1991 - "These results suggest that leukotoxin biosynthesized by neutrophils is an important contributor to lung injury in ARDS and associated coagulation abnormalities."
03/01/1990 - "[Leukotoxin and pulmonary injury]."
|1.||Proteins (Proteins, Gene)
|2.||Arcanobacterium pyogenes Pyolysin
|4.||Lymphocyte Function-Associated Antigen-1 (LFA-1)
|6.||Bacterial Proteins (Bacterial Protein)
|8.||Virulence Factors (Pathogenicity Factors)
|9.||Linoleic Acid (Linoleate)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Transplantation (Transplant Recipients)
|4.||Drug Therapy (Chemotherapy)